Depression can be a non-motor symptom, a risk factor, and even a co-morbidity of
Parkinson's disease (PD). In either case, depression seriously affects the quality of life of PD …

Parkinson's disease (PD) has for decades been considered a pure motor disorder and its
cardinal motor symptoms have been attributed to the loss of dopaminergic (DAergic) …

Accumulating evidences suggest that inflammation-mediated neurons dysfunction
participates in the initial and development of Parkinson's disease (PD), whereas …

Context Levodopa combined with traditional Chinese medicine has a synergistic effect on
Parkinson's disease (PD). Recently, we demonstrated that Nardostachys jatamansi (D. Don) …

Modeling Parkinson's disease remains a major challenge for preclinical researchers, as
existing models fail to reliably recapitulate all of the classic features of the disease, namely …

Accumulation of α-synuclein (α-syn) leading to the formation of insoluble intracellular
aggregates named Lewy bodies is proposed to have a significant role in Parkinson's …

The diagnosis of Parkinson's disease (PD) is solely based on movement disorders, but
several non-motor deficits are common in PD. Depression often precedes the movement …

Silent strokes occur more frequently than classic strokes; however, symptoms may go
unreported in spite of lasting tissue damage. A silent stroke may indicate elevated …

Parkinson's disease (PD) is a common neurodegenerative disease characterized by the loss
of dopaminergic neurons in the substantia nigra and the aggregation of α-synuclein into …

Previous studies have demonstrated that calcium channel blockers have protective effects
on damaged brains. In the present study, the protective effect of the calcium channel blocker …